Characterization of the Burkholderia mallei tonB mutant and its potential as a backbone strain for vaccine development

Keyphrases

• Vaccine Development 100%
• Burkholderia Mallei 100%
• Melioidosis 100%
• TonB 100%
• Inhalational 66%
• Glanders 66%
• Malleus 66%
• Challenge Study 66%
• Hypersecretion 33%
• Inflammatory Cytokines 33%
• Immunization 33%
• Immunogenicity 33%
• Target Organ 33%
• Chronic Infection 33%
• Balb C Mice 33%
• Inverse Correlation 33%
• Cross-protection 33%
• Protective Properties 33%
• Growth Kinetics 33%
• Infection Model 33%
• Iron Source 33%
• IgG1 33%
• Iron Acquisition 33%
• Heme Proteins 33%
• Siderophore 33%
• IgG2a 33%
• Post-challenge 33%
• Future Vaccines 33%
• Pseudomallei 33%
• Slow Growth 33%
• Attenuated Strain 33%
• Protection Studies 33%
• Animal Challenge 33%
• Pathological Damage 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Vaccine Development 100%
• Burkholderia mallei 100%
• Iron 100%
• Melioidosis 100%
• Glanders 66%
• Immunogenicity 33%
• Cytokine 33%
• Bagg Albino Mouse 33%
• Heme 33%
• Immunoglobulin M 33%
• Immunoglobulin G1 33%
• Immunoglobulin G2a 33%
• Siderophore 33%

Immunology and Microbiology

• Burkholderia mallei 100%
• Vertebral Column 100%
• Infection 100%
• Wild Type 66%
• Immunogenicity 33%
• Bagg Albino Mouse 33%
• Inflammatory Cytokine 33%
• Immunoglobulin M 33%
• Target Organ 33%
• Cross Protection 33%
• Colony Forming Unit S 33%
• Colony-Forming Unit 33%
• Immunoglobulin G1 33%
• Immunoglobulin G2a 33%
• Heme 33%